Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The copper intrauterine device (IUD) is a non-hormonal, T-shaped contraceptive device made from low-density polyethylene with barium sulfate added for X-ray opacity. It typically has copper wire wound around the vertical stem and copper collars on the horizontal arms, with a total copper surface area of 380 mm². The device works primarily by preventing fertilization through the cytotoxic effect of copper on sperm and by creating an inflammatory response in the uterus that prevents implantation of a fertilized egg. It is one of the most effective forms of long-acting reversible contraception with a failure rate of approximately 0.8% in the first year of use. The copper IUD can remain effective for up to 10-12 years and can also be used as emergency contraception when inserted within 5 days of unprotected intercourse.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on copper intrauterine device.